Variant report

Variant	nsv6512
Chromosome Location	chr9:27155677-27200455
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr9:27194446-27194714	GM12878	blood:	n/a	chr9:27194607-27194618
2	BRCA1	chr9:27181370-27181714	Hela-S3	cervix:	n/a	n/a
3	CBX3	chr9:27194266-27194999	HCT-116	colon:	n/a	n/a
4	CBX3	chr9:27193803-27195211	HCT-116	colon:	n/a	n/a
5	CEBPB	chr9:27194340-27195505	IMR90	lung:	n/a	n/a
6	CEBPB	chr9:27194367-27194834	Hela-S3	cervix:	n/a	n/a
7	CEBPB	chr9:27194317-27195157	HCT-116	colon:	n/a	n/a
8	CEBPB	chr9:27183716-27184199	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr9:27184636-27184875	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr9:27157238-27157513	IMR90	lung:	n/a	chr9:27157357-27157368 chr9:27157358-27157367 chr9:27157356-27157367 chr9:27157356-27157367 chr9:27157358-27157367 chr9:27157356-27157369 chr9:27157358-27157367 chr9:27157358-27157367 chr9:27157356-27157369
11	CEBPB	chr9:27157103-27157556	Hela-S3	cervix:	n/a	chr9:27157357-27157368 chr9:27157358-27157367 chr9:27157356-27157367 chr9:27157356-27157367 chr9:27157358-27157367 chr9:27157356-27157369 chr9:27157358-27157367 chr9:27157358-27157367 chr9:27157356-27157369
12	CEBPB	chr9:27181338-27181682	IMR90	lung:	n/a	n/a
13	CEBPB	chr9:27183814-27184166	IMR90	lung:	n/a	n/a
14	CEBPB	chr9:27168558-27168987	IMR90	lung:	n/a	chr9:27168771-27168783
15	CEBPB	chr9:27157265-27157494	HepG2	liver:	n/a	chr9:27157357-27157368 chr9:27157358-27157367 chr9:27157356-27157367 chr9:27157356-27157367 chr9:27157358-27157367 chr9:27157356-27157369 chr9:27157358-27157367 chr9:27157358-27157367 chr9:27157356-27157369
16	CEBPB	chr9:27183834-27184110	HepG2	liver:	n/a	n/a
17	CEBPB	chr9:27183887-27184087	K562	blood:	n/a	n/a
18	CEBPB	chr9:27166572-27166628	A549	lung:	n/a	n/a
19	CEBPB	chr9:27194269-27195045	HCT-116	colon:	n/a	n/a
20	CEBPB	chr9:27183807-27184156	A549	lung:	n/a	n/a
21	CEBPB	chr9:27181340-27181711	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr9:27198271-27198664	Hela-S3	cervix:	n/a	n/a
23	CEBPB	chr9:27183839-27184160	K562	blood:	n/a	n/a
24	CEBPB	chr9:27183927-27184064	K562	blood:	n/a	n/a
25	CTCF	chr9:27165768-27165918	Hela-S3	cervix:	n/a	chr9:27165842-27165851
26	CTCF	chr9:27165800-27165950	HCPEpiC	choroid plexus:	n/a	chr9:27165842-27165851
27	CTCF	chr9:27172942-27173051	MCF-7	breast:	n/a	n/a
28	CTCF	chr9:27165720-27165870	GM12873	blood:	n/a	chr9:27165842-27165851
29	CTCF	chr9:27198349-27198401	GM19240	blood:	n/a	n/a
30	CTCF	chr9:27157892-27157938	GM12892	blood:	n/a	n/a
31	CTCF	chr9:27165727-27165984	MCF-7	breast:	n/a	chr9:27165842-27165851
32	CTCF	chr9:27198276-27198459	A549	lung:	n/a	n/a
33	CTCF	chr9:27198300-27198450	AG10803	skin:	n/a	n/a
34	CTCF	chr9:27165720-27165980	MCF-7	breast:	n/a	chr9:27165842-27165851
35	CTCF	chr9:27172800-27172950	HCM	heart:	n/a	n/a
36	CTCF	chr9:27165680-27165830	AG04450	lung:	n/a	n/a
37	CTCF	chr9:27165784-27165922	Fibrobl	skin:	n/a	chr9:27165842-27165851
38	CTCF	chr9:27198377-27198410	Medullo	brain:	n/a	n/a
39	CTCF	chr9:27198320-27198470	AG04449	skin:	n/a	n/a
40	CTCF	chr9:27172700-27172850	HepG2	liver:	n/a	n/a
41	CTCF	chr9:27198318-27198430	GM19238	blood:	n/a	n/a
42	CTCF	chr9:27165720-27165870	GM12864	blood:	n/a	chr9:27165842-27165851
43	CTCF	chr9:27172952-27173053	NHEK	skin:	n/a	n/a
44	CTCF	chr9:27158126-27158189	Fibrobl	skin:	n/a	n/a
45	CTCF	chr9:27165740-27165890	GM12875	blood:	n/a	chr9:27165842-27165851
46	CTCF	chr9:27172900-27173050	SAEC	small airway:	n/a	n/a
47	CTCF	chr9:27165760-27165910	HepG2	liver:	n/a	chr9:27165842-27165851
48	CTCF	chr9:27198280-27198430	HA-sp	spinal cord:	n/a	n/a
49	CTCF	chr9:27157857-27157982	Hela-S3	cervix:	n/a	n/a
50	CTCF	chr9:27198325-27198438	GM12892	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:27033573..27034169-chr9:27165385..27166023,2	MCF-7	breast:

Variant related genes	Relation type
RNA5SP280	TF binding region

Extended variants
information (count: 1925 )
Associated
traits (count: 133 )

Variant overlapped rSNPs/rCNVs (count:1925 , 50 per page) page: 1 2 3 4 5 6 7 ... 39

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs556233663	chr9:27155723-27155724	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs557423647	chr9:27155730-27155731	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs369172950	chr9:27155739-27155740	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs541370129	chr9:27155751-27155752	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs369726901	chr9:27155758-27155759	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs543153364	chr9:27155784-27155785	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs10967740	chr9:27155789-27155790	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs573903014	chr9:27155803-27155804	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs375429880	chr9:27155818-27155819	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs541299712	chr9:27155822-27155823	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs79321664	chr9:27155830-27155831	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs397894614	chr9:27155832-27155833	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs192025887	chr9:27155869-27155870	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs184626464	chr9:27155883-27155884	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs551138910	chr9:27155894-27155895	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs370677271	chr9:27155925-27155926	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs563390242	chr9:27155948-27155949	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs530484480	chr9:27155950-27155951	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs548687811	chr9:27155952-27155953	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs567483749	chr9:27155993-27155994	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs10967741	chr9:27156079-27156080	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs529440159	chr9:27156094-27156095	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs116963745	chr9:27156101-27156102	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs559946973	chr9:27156109-27156110	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs142620920	chr9:27156191-27156192	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs370419852	chr9:27156206-27156207	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs528802607	chr9:27156221-27156222	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs539013980	chr9:27156245-27156246	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs17695057	chr9:27156297-27156298	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs575599323	chr9:27156303-27156304	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs572240121	chr9:27156457-27156458	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs187813441	chr9:27156517-27156518	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs150976742	chr9:27156529-27156530	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs79899091	chr9:27156534-27156535	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs7853262	chr9:27156574-27156575	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs561693353	chr9:27156669-27156670	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs76518189	chr9:27156744-27156745	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs543402215	chr9:27156795-27156796	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs577903166	chr9:27156823-27156824	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs545299452	chr9:27156846-27156847	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs193135163	chr9:27156886-27156887	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs184438043	chr9:27156907-27156908	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs548650903	chr9:27156986-27156987	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs504947	chr9:27156995-27156996	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs188983275	chr9:27156996-27156997	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs7856747	chr9:27157034-27157035	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs571821513	chr9:27157120-27157121	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs541298568	chr9:27157134-27157135	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs10967742	chr9:27157144-27157145	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs551278729	chr9:27157214-27157215	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:133)

Disease	PMID	Source
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Acute myeloid leukemia	19651601	CNVD
Coronary Disease	20032323	CNVD
Squamous cell cancer	20885788	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21732550	CNVD
Gastric cancer	22539939	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Metastatic melanoma	18483359	CNVD
Non-small cell lung cancer	20864512	CNVD
Cervical cancer	21062161	CNVD
Acute myeloid leukemia	16864856	CNVD
Glioblastoma	17090523	CNVD
Lung cancer	16773561	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16774939	CNVD
Bladder cancer	19088036	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	16977458	CNVD
Glioblastoma multiforme	17369134	CNVD
Chagasic megaesophagus	20163722	CNVD
Melanoma	19566914	CNVD
Squamous cell cancer	19047905	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Hodgkin''s lymphoma	18179710	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21858162	CNVD
Pancreatic cancer	21811587	CNVD
Barrett''s syndrome	19417022	CNVD
Myelofibrosis	22110671	CNVD
Urothelial cell carcinoma	18451213	CNVD
polycythaemia	22829968	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21364760	CNVD
Glioblastoma multiforme	21525872	CNVD
Epilepsy	22083797	CNVD
Cancer	22183965	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
early-passage human iPS cells	21368824	CNVD
Lung cancer	20668451	CNVD
Lung adenocarcinoma	21935476	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:435 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:27150800-27158000	Weak transcription	Spleen	Spleen
2	chr9:27151000-27155800	Enhancers	Placenta Amnion	Placenta Amnion
3	chr9:27151000-27158000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr9:27151000-27172800	Weak transcription	Left Ventricle	heart
5	chr9:27151000-27229200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr9:27151200-27164800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
7	chr9:27151800-27158000	Weak transcription	Lung	lung
8	chr9:27151800-27165000	Weak transcription	Stomach Smooth Muscle	stomach
9	chr9:27152000-27174600	Weak transcription	Fetal Muscle Leg	muscle
10	chr9:27152200-27165400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
11	chr9:27152400-27156600	Weak transcription	Hela-S3	cervix
12	chr9:27152400-27157800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
13	chr9:27152400-27181600	Weak transcription	Adipose Nuclei	Adipose
14	chr9:27154400-27155800	Enhancers	Muscle Satellite Cultured Cells	--
15	chr9:27154400-27155800	Enhancers	HSMMtube	muscle
16	chr9:27154400-27158000	Enhancers	Osteobl	bone
17	chr9:27154600-27155800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
18	chr9:27155200-27156400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
19	chr9:27155400-27155800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
20	chr9:27155400-27155800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr9:27155400-27155800	Enhancers	HUVEC	blood vessel
22	chr9:27155400-27156400	Weak transcription	Aorta	Aorta
23	chr9:27155400-27156800	Weak transcription	HMEC	breast
24	chr9:27155400-27157600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr9:27155400-27157600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr9:27155400-27157800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
27	chr9:27155400-27157800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr9:27155400-27159000	Weak transcription	Colon Smooth Muscle	Colon
29	chr9:27155400-27161400	Weak transcription	Fetal Lung	lung
30	chr9:27155400-27164600	Weak transcription	Fetal Stomach	stomach
31	chr9:27155600-27156800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr9:27155600-27157000	Weak transcription	NHEK	skin
33	chr9:27155600-27159000	Weak transcription	Fetal Heart	heart
34	chr9:27155800-27156200	Weak transcription	Placenta Amnion	Placenta Amnion
35	chr9:27155800-27156800	Weak transcription	Muscle Satellite Cultured Cells	--
36	chr9:27155800-27157200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr9:27155800-27157600	Weak transcription	HUVEC	blood vessel
38	chr9:27156200-27158200	Enhancers	Placenta Amnion	Placenta Amnion
39	chr9:27156400-27156600	Enhancers	Aorta	Aorta
40	chr9:27156400-27157800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
41	chr9:27156600-27157800	Enhancers	Hela-S3	cervix
42	chr9:27156800-27157200	Enhancers	Muscle Satellite Cultured Cells	--
43	chr9:27156800-27157400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
44	chr9:27156800-27157600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr9:27156800-27157800	Enhancers	HMEC	breast
46	chr9:27157000-27158000	Enhancers	NHEK	skin
47	chr9:27157200-27158000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
48	chr9:27157200-27162000	Weak transcription	Muscle Satellite Cultured Cells	--
49	chr9:27157400-27165400	Weak transcription	H1 Cell Line	embryonic stem cell
50	chr9:27157600-27157800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links